Impact of the phased abolition of co‐payments on the utilisation of selected prescription medicines in Wales
M. Fasihul Alam,
David Cohen,
Frank Dunstan,
Dyfrig Hughes and
Philip Routledge
Health Economics, 2018, vol. 27, issue 1, 236-243
Abstract:
We have taken advantage of a natural experiment to measure the impact of the phased abolition of prescription co‐payments in Wales. We investigated 3 study periods covering the phased abolition: from £6 to £4, £4 to £3, and £3 to £0. A difference‐in‐difference modelling was adopted and applied to monthly UK general practice level dispensing data on 14 selected medicines which had the highest percentage of items dispensed subject to a co‐payment prior to abolition. Dispensing from a comparator region (North East of England) with similar health and socio‐economic characteristics to Wales, and where prescription co‐payments continued during the study periods, was used to isolate any non‐price effects on dispensing in Wales. Results show a small increase in dispensing of 14 selected medicines versus the comparator. Compared with NE England, monthly average Welsh dispensing was increased by 11.93 items (7.67%; 95% CI [7.2%, 8.1%]), 6.37 items (3.38%; 95% CI [2.9%, 3.7%]) and 9.18 items (4.54%; 95% CI [4.2%, 4.9%]) per practice per 1,000 population during the periods when co‐payment was reduced. Price elasticities of the selected medicines utilisation were −0.23, −0.13, and −0.04 in 3 analyses, suggesting the abolition of co‐payment had small effect on Welsh dispensing.
Date: 2018
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (1)
Downloads: (external link)
https://doi.org/10.1002/hec.3530
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:wly:hlthec:v:27:y:2018:i:1:p:236-243
Access Statistics for this article
Health Economics is currently edited by Alan Maynard, John Hutton and Andrew Jones
More articles in Health Economics from John Wiley & Sons, Ltd.
Bibliographic data for series maintained by Wiley Content Delivery ().